ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #8,587Hybrid

Journal of Cardiovascular Pharmacology

Acronym:jcvp
•
Abbreviation (ISO):J. CARDIOVASC. PHARMACOL
•
Identifier (ISSN):0160-2446(Print)/1533-4023(Online)
•
Publisher:Lippincott Williams and Wilkins Ltd.
Clarivate IF (2026)
2.5↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Cardiovascular Pharmacology

WoS Q2
12452.2320182.3720192.620203.120213.272022320232.620242.220252.52026
Annual Impact Factor Metric
Current (2026):2.5
Scopus SJR & RankScopus Q2
0.676
#8,587

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
113

113 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate3.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
171articles/year
15.89% Gold OA•73.12% Original Research

Aims & Scope

Journal of Cardiovascular Pharmacology is a peer reviewed, multidisciplinary journal that publishes original articles and pertinent review articles on basic and clinical aspects of cardiovascular pharmacology. The Journal encourages submission in all aspects of cardiovascular pharmacology/medicine including, but not limited to: stroke, kidney disease, lipid disorders, diabetes, systemic and pulmonary hypertension, cancer angiogenesis, neural and hormonal control of the circulation, sepsis, neurodegenerative diseases with a vascular component, cardiac and vascular remodeling, heart failure, angina, anticoagulants/antiplatelet agents, drugs/agents that affect vascular smooth muscle, and arrhythmias. Appropriate subjects include new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects, application of drugs to gain novel insights into physiology or pathological conditions, clinical results with new and established agents, and novel methods. The focus is on pharmacology in its broadest applications, incorporating not only traditional approaches, but new approaches to the development of pharmacological agents and the prevention and treatment of cardiovascular diseases. Please note that JCVP does not publish work based on biological extracts of mixed and uncertain chemical composition or unknown concentration.

Topics Covered (Recognized by AI)
Medicine98%Internal medicine91.8%Biology90.8%Endocrinology77.3%Chemistry72.6%Biochemistry61.2%Cardiology57.6%Genetics56.2%Radiology47.1%Blood pressure40.9%Pharmacology40.7%Psychology39.8%Organic chemistry38.7%Receptor38.5%Anesthesia37.3%Psychiatry24.3%Surgery23.1%Pathology22.5%Physics21.9%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CARDIAC & CARDIOVASCULAR SYSTEMS

Q2
Rank111/237
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank205/356
IndexSCIE
JCISCIE2026

CARDIAC & CARDIOVASCULAR SYSTEMS

Q3
Rank120/237
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank211/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.5
Articles / Year92
Total Citations18
2025
IF2.2
Articles / Year121
Total Citations271
2024
IF2.6
Articles / Year132
Total Citations515
2023
IF3
Articles / Year145
Total Citations922
2022
IF3.271
Articles / Year182
Total Citations1,444

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,587Scopus Q2SCImago Profile
Scopus Coverage:1979-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.676

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.09

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,085 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations977
3-Year Documents471
Citable Documents412

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cardiology and Cardiovascular MedicineQ2
Medicine (miscellaneous)Q2
PharmacologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区CARDIAC & CARDIOVASCULAR SYSTEMS
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Cardiovascular Pharmacology (acronym: jcvp, abbr: J. CARDIOVASC. PHARMACOL, ISSN: 0160-2446) is a peer-reviewed international scholarly journal in the field of Medicine, published by Lippincott Williams and Wilkins Ltd. in United States since 1979. The periodical holds a Journal Impact Factor (JIF) of 2.50, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.676 (Q2), an H-index of 113.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 171 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,085 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Lippincott Williams and Wilkins Ltd.
Publication Language
English
Frequency
Monthly
Founding Year
1979
Indexing & Databases
SCIEScopusPubMed
Editorial Address
LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 5a6bb415-3224-4fe5-899a-f16d05376379
Database Updated: 2026-09-28